The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 3-9 March 2019 and includes updates on Leishmaniasis and Zika virus disease, Middle East respiratory syndrome coronavirus (MERS-CoV), measles, Ebola virus disease, influenza, Rift Valley fever and mass gathering for Carnival in Brazil.
This rapid risk assessment (RRA) addresses the risk of importation of Rift Valley fever (RVF) virus (RVFV) and further spread of the virus within the European Union/European Economic Area (EU/EEA) in relation to the recent increase in cases reported on Mayotte, France.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 24 February-2 March 2019 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), cholera, dengue, Ebola virus disease, influenza, Rift Valley fever and Legionnaires' disease.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 27 January-2 February 2019 and includes updates on Ebola virus disease, influenza, influenza A(H9N2), mass gathering monitoring for World Youth Day in Panama, Salmonella Poona, Rift Valley fever and yellow fever.
Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. In 2016, 29 EU/EEA countries reported 5 631 confirmed shigellosis cases.
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. In 2016, two EU/EEA countries reported six laboratory-confirmed anthrax cases: Romania (5) and Spain (1). The remaining 28 reporting countries notified no cases.
For 2016, EU/EEA countries reported three travel-related cases of Rift Valley fever. All cases reported by EU/EEA countries between 2012 and 2016 were travel-related, with probable infection in Comoros, Egypt, Ghana, Mali or Uganda.